1 Prevalence of Integrons and Antibiotic Resistance Pattern in Isolated from Clinical Samples of Iranian Patients: A Systematic Review and Meta-analysis.

2 distribution of class i integron among isolates of acinetobacter baumannii recoverd from burn patients

3 site-specific recombination at xerc/d sites mediates the formation and resolution of plasmid co-integrates carrying a blaoxa-58- and tnapha6-resistance module in acinetobacter baumannii

4 efficacy of bacteriophage treatment against carbapenem-resistant acinetobacter baumannii in galleria mellonella larvae and a mouse model of acute pneumonia

5 facial ulcerations due to acinetobacter baumannii: vessel thrombosis with bacterial mycelia

6 association between mutations in gyra and parc genes of acinetobacter baumannii clinical isolates and ciprofloxacin resistance

7 biofilm formation in clinical isolates of nosocomial acinetobacter baumannii and its relationship with multidrug resistance

8 rapid detection of acinetobacter baumannii and molecular epidemiology of carbapenem-resistant a.baumannii in two comprehensive hospitals of beijing, china

9 erratum: an other-race effect for configural and featural processing of faces: upper and lower face regions play different roles

10 two new lytic bacteriophages of the myoviridae family against carbapenem-resistant acinetobacter baumannii

11 kinetics and novel degradation pathway of permethrin in acinetobacter baumannii zh-14

12 biotyping, serotyping and ribotyping as epidemiological tools in the evaluation of acinetobacter baumannii dissemination in hospital units, sorocaba, são paulo, brazil

13 relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in acinetobacter baumannii

14 the antibacterial activity evaluation of the nanoparticles of silver on acinetobacter baumannii

15 identification of kpc-producing pseudomonas aeruginosa and acinetobacter baumanniiin a burned infant: a case report

16 heavy metal toxicity in armed conflicts potentiates amr in a. baumannii by selecting for antibiotic and heavy metal co-resistance mechanisms

17 Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii

18 Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

19 Rapid simultaneous detection of blaoxa-23, Ade-B, int-1, and ISCR-1 in multidrug-resistant Acinetobacter baumannii using single-tube multiplex PCR and high resolution melting assay

20 Characterization of a small plasmid carrying the carbapenem resistance gene blaOXA-72 from community-acquired Acinetobacter baumannii sequence type 880 in China

21 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

22 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

23 Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin

24 In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

25 In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

26 Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection

27 Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments

28 Extensively drug-resistant Acinetobacter baumannii and Proteeae association in a Romanian intensive care unit: risk factors for acquisition

29 Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality

30 Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran

31 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations

32 Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities

33 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

34 Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality

35 Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

36 Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study

37 Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii

38 Molecular evaluation of colistin-resistant gene expression changes in Acinetobacter baumannii with real-time polymerase chain reaction

39 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

40 Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients

41 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

42 Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii

43 Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

44 Rapid simultaneous detection of blaoxa-23, Ade-B, int-1, and ISCR-1 in multidrug-resistant Acinetobacter baumannii using single-tube multiplex PCR and high resolution melting assay

45 Characterization of a small plasmid carrying the carbapenem resistance gene blaOXA-72 from community-acquired Acinetobacter baumannii sequence type 880 in China

46 Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii

47 Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

48 Rapid simultaneous detection of blaoxa-23, Ade-B, int-1, and ISCR-1 in multidrug-resistant Acinetobacter baumannii using single-tube multiplex PCR and high resolution melting assay

49 Characterization of a small plasmid carrying the carbapenem resistance gene blaOXA-72 from community-acquired Acinetobacter baumannii sequence type 880 in China

50 Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

51 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

52 Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin

53 In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

54 In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

55 Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection

56 Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments

57 Extensively drug-resistant Acinetobacter baumannii and Proteeae association in a Romanian intensive care unit: risk factors for acquisition

58 Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality

59 Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran

60 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations

61 Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities

62 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

63 Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality

64 Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

65 Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study

66 Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii

67 Molecular evaluation of colistin-resistant gene expression changes in Acinetobacter baumannii with real-time polymerase chain reaction

68 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

69 Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients

70 Visual and rapid detection of Acinetobacter baumannii by a multiple cross displacement amplification combined with nanoparticles-based biosensor assay

71 Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions between 2-Aminoimidazoles and the Response Regulators BfmR from Acinetobacter baumannii and QseB from Francisella spp.

72 In silico and in vitro analysis of quorum quenching active phytochemicals from the ethanolic extract of medicinal plants against quorum sensing mediated virulence factors of acinetobacter baumannii

73 [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].

74 Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.

75 Cryo-electron Microscopy Structure of the Acinetobacter baumannii 70S Ribosome and Implications for New Antibiotic Development.

76 High prevalence of TEM, VIM, and OXA-2 beta-lactamases and clonal diversity among Acinetobacter baumannii isolates in Turkey.

77 Acinetobacter baumannii detected on mCCDA medium in a waste stabilisation pond

78 Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The Preantibiotic Era Has Returned

79 Acinetobacter baumannii detected on modified charcoal–cefoperazone–deoxycholate agar in a waste stabilization pond

80 Degradation of butachlor and propanil by Pseudomonas sp. strain But2 and Acinetobacter baumannii strain DT.

81 Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

82 multidrug-resistant acinetobacter baumannii: an emerging health threat in aseer region, kingdom of saudi arabia

83 studies on molecular epidemiology and antibiotic resistance related genes of multi-resistant strains of acinetobacter baumannii isolated from intensive care units

84 structural relationship of the lipid a acyl groups to activation of murine toll-like receptor 4 by lipopolysaccharides from pathogenic strains of burkholderia mallei, acinetobacter baumannii and pseudomonas aeruginosa

85 fluorescence-based flow sorting in parallel with transposon insertion site sequencing identifies multidrug efflux systems in acinetobacter baumannii

86 carbapenem resistance in acinetobacter baumannii and other acinetobacter spp. causing neonatal sepsis: focus on ndm-1 and its linkage to isaba125

87 phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant acinetobacter baumannii in mice

88 characterization of carbapenem-resistant acinetobacter baumannii strains isolated from hospitalized patients in palestine

89 insights on the horizontal gene transfer of carbapenemase determinants in the opportunistic pathogen acinetobacter baumannii

90 Transcriptional regulation of the iac locus from Acinetobacter baumannii by the phytohormone indole-3-acetic acid

91 Complete genome sequence of collection strain acinetobacter baumannii ATCC BAA-1790, used as a model to study the antibiotic resistance reversion induced by iodine-containing complexes

92 Serious Infections in the Intensive Care Unit: Pseudomonas aeruginosa and Acinetobacter baumannii

93 Serious Infections in the Intensive Care Unit: Pseudomonas aeruginosa and Acinetobacter baumannii

94 Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii

95 Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa

96 Serious Infections in the Intensive Care Unit: Pseudomonas Aeruginosa and Acinetobacter Baumannii Cme Course Number: 408 Course Date: September 2006-September 2007

97 Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study

98 Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004

Keyword Connections

Journals

Research Groups

Bibliographies